Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Knobler, R; Berlin, G; Calzavara-Pinton, P; Greinix, H; Jaksch, P; Laroche, L; Ludvigsson, J; Quaglino, P; Reinisch, W; Scarisbrick, J; Schwarz, T; Wolf, P; Arenberger, P; Assaf, C; Bagot, M; Barr, M; Bohbot, A; Bruckner-Tuderman, L; Dreno, B; Enk, A; French, L; Gniadecki, R; Gollnick, H; Hertl, M; Jantschitsch, C; Jung, A; Just, U; Klemke, CD; Lippert, U; Luger, T; Papadavid, E; Pehamberger, H; Ranki, A; Stadler, R; Sterry, W; Wolf, IH; Worm, M; Zic, J; Zouboulis, CC; Hillen, U.
Guidelines on the use of extracorporeal photopheresis.
J Eur Acad Dermatol Venereol. 2014; 28 Suppl 1:1-37
Doi: 10.1111/jdv.12311
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
-
Greinix Hildegard
-
Wolf Ingrid
-
Wolf Peter
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
After the first investigational study on the use of extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma was published in 1983 with its subsequent recognition by the FDA for its refractory forms, the technology has shown significant promise in the treatment of other severe and refractory conditions in a multi-disciplinary setting. Among the major studied conditions are graft versus host disease after allogeneic bone marrow transplantation, systemic sclerosis, solid organ transplant rejection and inflammatory bowel disease.
In order to provide recognized expert practical guidelines for the use of this technology for all indications the European Dermatology Forum (EDF) proceeded to address these questions in the hands of the recognized experts within and outside the field of dermatology. This was done using the recognized and approved guidelines of EDF for this task.
These guidelines provide at present the most comprehensive available expert recommendations for the use of extracorporeal photopheresis based on the available published literature and expert consensus opinion.
© 2013 The Authors. Journal of the European Academy of Dermatology and Venereology published by John Wiley & Sons Ltd on behalf of European Academy of Dermatology and Venereology.
- Find related publications in this database (using NLM MeSH Indexing)
-
Autoimmune Diseases - drug therapy
-
Graft Rejection - drug therapy
-
Graft vs Host Disease - drug therapy
-
Humans -
-
Inflammatory Bowel Diseases - drug therapy
-
Lymphoma, T-Cell, Cutaneous - drug therapy
-
Photopheresis - methods Photopheresis - utilization
-
Photosensitizing Agents - therapeutic use
-
Scleroderma, Systemic - drug therapy
-
Skin Neoplasms - drug therapy
-
Treatment Outcome -